Concentration-QT Study of Paroxetine in Healthy Adults

Trial Identifier:	219882
Sponsor:	GlaxoSmithKline
Start Date:	October 2023
Primary Completion Date:	January 2024
Study Completion Date:	January 2024
Condition:	Generalized Anxiety Disorder

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language	Description

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
United Kingdom	London, United Kingdom, HA1 3UJ

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.